#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5233078	B	Inhibition of human recombinant tissue transglutaminase expressed in Escherichia coli using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring Kinact incubated for 20 mins by colorimetric analysis	Homo sapiens	12		assay format	Scientific Literature
2.	ALA5233079	A	Metabolic stability in pooled cryopreserved human hepatocytes assessed as half-life at 1 uM measured upto 120 mins by LC-MS/MS analysis	Homo sapiens	3		cell-based format	Scientific Literature
3.	ALA5233080	A	Metabolic stability in human whole blood assessed as half-life at 1 to 5 uM measured upto 120 mins by LC-MS/MS analysis	Homo sapiens	3		tissue-based format	Scientific Literature
4.	ALA5233084	B	Irreversible inhibition of human recombinant tissue transglutaminase expressed in Escherichia coli using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring KI incubated for 20 mins by colorimetric analysis	Homo sapiens	12		assay format	Scientific Literature
5.	ALA5233088	B	Irreversible inhibition of human recombinant tissue transglutaminase expressed in Escherichia coli using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring Kinact/Ki ratio incubated for 20 mins by colorimetric analysis	Homo sapiens	11		assay format	Scientific Literature
6.	ALA5233090	B	Irreversible inhibition of human recombinant tissue transglutaminase expressed in Escherichia coli using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring Kinact/Ki ratio by linear regression analysis	Homo sapiens	11		assay format	Scientific Literature
7.	ALA5233092	P	GSH reactivity in aqueous buffer assessed as GSH adduct formation by measuring corrected intrinsic second order rate constant (K2 corrected) by HPLC analysis		3		small-molecule physicochemical format	Scientific Literature
8.	ALA5233093	B	Irreversible inhibition of human TG2 using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring observed binding constant incubated for 20 mins by colorimetric assay	Homo sapiens	4		single protein format	Scientific Literature
9.	ALA5233094	B	Irreversible inhibition of human TG1 using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring observed binding constant incubated for 100 mins by colorimetric assay	Homo sapiens	4		single protein format	Scientific Literature
10.	ALA5233095	B	Irreversible inhibition of human TG6 using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring observed binding constant incubated for 60 mins by colorimetric assay	Homo sapiens	4		single protein format	Scientific Literature
11.	ALA5233096	B	Reversible inhibition of activated human TG3 using peptidic FRET-quenched probe A101 as substrate by fluorescence based assay relative to control	Homo sapiens	4		single protein format	Scientific Literature
12.	ALA5233098	B	Reversible inhibition of human factor XIIIa using peptidic FRET-quenched probe A101 as substrate by fluorescence based assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
13.	ALA5233101	P	Ratio of Kinact/Ki for inhibition of human tissue transglutaminase assessed as substrate hydrolysis to corrected second order rate constant (K2 corrected) for GSH reactivity in aqueous buffer assessed as GSH adduct formation		3		small-molecule physicochemical format	Scientific Literature